Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Epiminder Ltd. ( (AU:EPI) ) has provided an update.
Epiminder Limited has appointed MVAB Audit Pty Ltd as its new auditor, following the restructuring of MVAB Assurance’s audit practice so that audits will now be conducted by the authorised audit company MVAB Audit. The change has received the required consent from the corporate regulator, and shareholders will be asked to confirm the appointment at the company’s next Annual General Meeting, marking a formal transition in Epiminder’s audit oversight structure.
The appointment of MVAB Audit reflects a procedural shift rather than a change in audit firm relationships, suggesting limited operational disruption while aligning Epiminder with updated audit practice arrangements. For investors and other stakeholders, the move underscores the company’s compliance with Australian corporate governance requirements and maintains continuity in its external financial assurance framework.
The most recent analyst rating on (AU:EPI) stock is a Buy with a A$2.33 price target. To see the full list of analyst forecasts on Epiminder Ltd. stock, see the AU:EPI Stock Forecast page.
More about Epiminder Ltd.
Epiminder Limited is a Melbourne-based medical device and information solutions company focused on diagnostic and treatment tools for epilepsy and other seizure disorders requiring continuous monitoring. Its flagship product, Minder, is a minimally invasive device that enables long-term, real-world electrographic brain activity monitoring, allowing clinicians to remotely assess patients’ underlying conditions and treatment effectiveness.
Average Trading Volume: 83,155
Learn more about EPI stock on TipRanks’ Stock Analysis page.